COMP <GO>
MCK vs MRK // FREE CASH FLOW YIELD
McKesson Corporation (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: MCK 6
— MRK 8
▲ FREE CASH FLOW YIELD LEADER: MCK
LAST: $994.58 (+1.40%) • MKT CAP: $114.36B
fcf-yield
5.00%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
fcf-yield
3.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MCK VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MCK | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.60% | 74.80% | -71.20 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 38.60% | 20.70% | +17.90 | MCK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.5x | 15.3x | +4.20 | MRK | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 5.00% | 3.42% | +1.58 | MCK | /fcf-yield <GO> |
| Operating Margin | 1.50% | 34.30% | -32.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | 1.20% | 28.10% | -26.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 12.40% | 1.30% | +11.10 | MCK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.33% | 2.26% | -1.93 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.96 | 5.19 | +1.77 | MCK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.60% | +0.10 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.7 | 56.9 | +3.80 | MCK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.92 | +0.03 | MCK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 18.4x | +1.80 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $114.36B | $361.02B | -$246.66B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MCK REV | MRK REV | MCK GROSS % | MRK GROSS % | MCK FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $403.43B | $65.01B | 3.6% | 74.8% | $5.72B | $12.36B |
| FY 2024 | $359.05B | $64.17B | 3.7% | 76.3% | $5.55B | $18.10B |
| FY 2023 | $308.95B | $60.12B | 44.0% | 44.0% | -$9.59B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MCK // BETA 0.95
MRK // BETA 0.92